Mobile

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of E5555, and its Effects on Markers of Intravascular Inflammation in Subjects with Coronary Artery Disease

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-006029-94

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the safety and tolerability of E5555 in patients with coronary artery disease.

Critère d'inclusion

  • Coronary (artery) disease

Liens